Article 1: Counterfeit Medicines and Public Health Governance in India
Why in News: Delhi Police recently busted an inter-state racket involved in stealing government-supplied medicines meant for poor patients, relabelling them with forged tags, and illegally selling them across Delhi-NCR and Northeastern states.
Key Details
- Delhi Police arrested four accused involved in diversion and illegal resale of life-saving medicines. The racket operated through a network spanning Delhi, Uttar Pradesh, Punjab, Assam, and Manipur.
- The seized medicines included insulin, Hepatitis-B vaccines, rabies vaccines, anti-snake venom, and human albumin. These are essential medicines used in emergency care and public health programmes.
- The accused allegedly removed original hospital labels and replaced them with forged packaging before resale. This tampering created risks of expired, compromised, or improperly stored medicines entering the market.
- Preliminary investigation suggests the use of hawala channels for financial transactions linked to the illegal trade. These points towards organised criminal networks and possible money laundering dimensions.
Public Health System and Free Medicine Schemes
- India provides free essential medicines through government hospitals and public health centres. This is aimed at reducing out-of-pocket expenditure and improving healthcare access for poorer sections.
- Several states operate free drug schemes under the National Health Mission (NHM). These schemes are particularly important for chronic diseases like diabetes and infectious diseases like Hepatitis-B.
- Leakage and diversion of medicines weaken the credibility of public healthcare systems. It directly affects vulnerable patients who depend on government support for survival.
- Ensuring uninterrupted medicine supply is a core component of Universal Health Coverage (UHC). Any disruption can increase inequality in healthcare access and treatment outcomes.
Counterfeit and Spurious Medicines
- The Drugs and Cosmetics Act regulates manufacture, sale, and distribution of medicines in India. It aims to ensure safety, efficacy, and quality of pharmaceutical products.
- Spurious or counterfeit medicines are drugs deliberately mislabelled regarding identity or source. They may contain incorrect ingredients, harmful substances, or inadequate active components.
- Sale of fake medicines is a serious public health offence because it can lead to treatment failure or death. It also contributes to antimicrobial resistance and loss of trust in healthcare systems.
- The Act prescribes penalties including imprisonment and fines for manufacture or sale of counterfeit drugs. Enforcement responsibility lies with drug inspectors, police authorities, and regulatory agencies.
Supply Chain Diversion and Black Marketing
- The racket allegedly sourced medicines meant for free distribution from government hospitals in Uttar Pradesh. Local contacts diverted unused or surplus stock into illegal commercial channels.
- To avoid detection, consignments were routed through distant locations such as Guwahati before reaching Delhi. This reflects sophisticated logistical planning commonly seen in organised criminal networks.
- Relabelling and repackaging were used to conceal the origin of medicines. Forged labels removed government hospital markings and enabled resale in the open market.
- Illegal medicine trade creates parallel informal pharmaceutical markets lacking regulatory oversight. This increases the risk of unsafe drugs reaching consumers across multiple states.
Public Health Risks and Ethical Concerns
- Life-saving medicines like insulin and anti-rabies vaccines require strict storage and temperature conditions. Improper handling can reduce effectiveness and endanger patient safety.
- Compromised medicines may fail during critical treatment situations such as trauma care or infections. This can directly increase mortality and morbidity among patients.
- The diversion of medicines intended for poor patients raises serious ethical and governance concerns. It reflects misuse of welfare-oriented public health infrastructure for private profit.
- Public trust in government healthcare institutions can decline if such incidents become frequent. This may discourage economically weaker sections from relying on public health services.
Organised Crime and Hawala Networks
- Preliminary evidence suggests that hawala channels may have been used for financial transactions. Hawala systems operate outside formal banking channels and are difficult to trace.
- Such illegal financial mechanisms are often associated with tax evasion, money laundering, and organised crime. They undermine financial transparency and regulatory oversight.
- The case highlights the growing intersection between economic offences and public health crimes. Criminal networks increasingly exploit weak monitoring systems in essential sectors.
- Financial investigation agencies may examine links under anti-money laundering frameworks. This could widen the investigation beyond counterfeit medicines alone.
India’s Pharmaceutical Sector and Regulatory Challenges
- India is known as the “Pharmacy of the World” due to its large generic medicine industry. The country supplies affordable medicines globally, especially to developing nations.
- Despite strong manufacturing capacity, regulatory enforcement remains uneven across states. Weak monitoring increases vulnerability to counterfeit drug networks.
- The pharmaceutical supply chain involves manufacturers, distributors, hospitals, pharmacies, and transport systems. Any gap in monitoring can enable diversion or adulteration of medicines.
- Digital tracking systems and barcode-based verification are increasingly being promoted. These technologies can improve traceability and reduce medicine theft.
Role of Law Enforcement and Institutional Coordination
- Delhi Police coordinated investigations across multiple states to dismantle the racket. Inter-state cooperation is essential because pharmaceutical crimes often involve complex supply chains.
- Drug control authorities and police agencies work together under legal frameworks to detect violations. Their coordination is important for protecting public health and consumer safety.
- Regular inspections and audits of hospital medicine inventories can reduce diversion risks. Stronger accountability mechanisms are needed at the local level.
- Public awareness regarding counterfeit medicines is equally important. Consumers should verify medicine packaging and purchase drugs only from authorised sources.
Way Forward
- Strengthen end-to-end digital tracking of medicines distributed through government health schemes. This can improve transparency and reduce leakages in supply chains.
- Enhance coordination between police, drug regulators, and financial intelligence agencies. A multi-agency approach is necessary to tackle organised pharmaceutical crime.
- Improve storage, auditing, and inventory management systems in public hospitals. Regular verification can help identify diversion at an early stage.
- Promote stricter penalties and faster prosecution in counterfeit medicine cases. This will create stronger deterrence against public health-related crimes.
Conclusion
The counterfeit medicine racket exposes serious gaps in India’s public health supply chain and regulatory enforcement. Diversion of life-saving medicines not only threatens patient safety but also undermines trust in welfare-oriented healthcare systems. Strengthening monitoring, institutional coordination, and legal enforcement is essential to safeguard public health and ensure equitable access to essential medicines.
EXPECTED QUESTION FOR UPSC CSE
Prelims MCQ
Q. With reference to counterfeit medicines and pharmaceutical regulation in India, consider the following statements:
- The Drugs and Cosmetics Act regulates the manufacture and sale of medicines in India.
- Counterfeit medicines can contribute to antimicrobial resistance and treatment failure.
- Hawala transactions are fully regulated under the formal banking system in India.
How many of the above statements are correct?
(a) Only one
(b) Only two
(c) All three
(d) None
Answer: (b)